MDR 2020

Prepare for change
in 3 steps

MEDICAL DEVICE REGULATION

1

IDENTIFY THE CLASS OF YOUR MEDICAL DEVICE

Start by defining the intended use of your software, so you can learn which standards it needs to comply with. This will help you to identify your software’s class too. As part of the MDR coming into force in a few months, almost all software-driven medical devices or apps will be up-classified into Class IIa or Class III. Read Rule 11 of the MDR for more information.

2

DIVE DEEP INTO THE MDR

The only way to fully understand MDR is to study it inside-out! Make sure to take notes on where it will impact you. Reading our guidebook “Medical Devices Regulation 2020 - Everything You Need to Know” is a good starting point: it summarises what will change and what will stay the same.

3

CREATE A COMPREHENSIVE PLAN

This will be a major task; one that, again, our guide can help you prepare for. Start by compiling a list of tasks, and don’t forget to include a timeline and to map out resource allocation. To give you a head start, here are a few examples of the must-dos:
• Put in place a quality management system
• Assign a team responsible for ensuring compliance with the new regulation
• Create a risk management system
• Define a process for your software’s clinical evaluation
• Establish a post-market surveillance plan

FIND THE RIGHT PARTNER TO HELP YOU UNDERSTAND AND IMPLEMENT SOME OF THESE CHANGES

Critical Software has over twenty years’ experience in software development and testing for the most demanding industries and regulations. With our knowledge of medical device standards, like the EU’s new Medical Device Regulation and IEC 62304, we’re in a unique position to tackle the challenges medical device manufacturers face. Our software development, testing and certification expertise ensures full compliance with industry standards – right up to Class III devices.

CONTACTS

Critical Software GmbH
Agnes-Pockels-Bogen 1
80992 München
Germany

Critical Software SA
Parque Ind. de Taveiro, lote 49
3045-504 Coimbra
Portugal

Critical Software Technologies
4 Benham Road
Southampton Science Park, Chilworth
Southampton SO16 7QJ
United Kingdom

Go to article: Home | The light is coming Go to article: In This IssueGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: ContentsGo to article: NSFGo to article: The Medical Industry BriefingGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: NewsGo to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: Covid-19 executive briefing by GlobalDataGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Remote healthcare: ‘second battlefield’ in the fight against Covid-19Go to article: Market value growth of diagnostic imaging devices expected during Covid-19 outbreakGo to article: Emerging technologies are helping China fight Covid-19Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: Can car manufacturers help with the need for ventilators in the UK?Go to article: Equflow Company Insight Go to article: Equflow Go to article: Biotechs continue to favour US despite China IPO reforms, say expertsGo to article: Repsol Company Insight Go to article: Repsol Go to article: Facilitating medical innovation: tech incubators to watch in 2020Go to article: Review Display SystemsGo to article: Peezy Midstream: meet the most unusual item in this year’s Oscars gift bagGo to article: Schurter Go to article: Robotic surgery: a race to the topGo to article: Maraca InternationalGo to article: Living livers: how to extend the transplant windowGo to article: device25Go to article: Into the light: why photonics is reshaping modern medicineGo to article: Lenzing Plastics Company InsightGo to article: Lenzing PlasticsGo to article: Q&A: Trialling virtual workers in the NHS Go to article: SemecsGo to article: SightPlus: the virtual reality vision aid restoring eyesight Go to article: TiodizeGo to article: Healing machine: combining robotics and sonics to target malignant cancerGo to article: Acad GroupGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: Tricor SystemsGo to article: The key list powered by GlobaldataGo to article: Deals in brief powered by GlobaldataGo to article: Smiths InterconnectGo to article: EventsGo to article: Next Issue